Published in Cancer Weekly, June 16th, 2009
"There is just a glimmer of an upward trend for biotech as evidenced by the performance of the Burrill Mid-Cap Biotech Index, whose members have been particularly hard hit during this economic downturn," said G. Steven Burrill, CEO, Burrill & Company, a San Francisco...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.